Articles

Coronavirus cases in this country topped 11 million over the weekend, making today’s news from Moderna, Inc. (Nasdaq: MRNA) that much more significant. The pharmaceutical company announced its...
When I was a 30-year-old newbie retail stockbroker at Merrill Lynch, I thought I knew everything. You couldn’t tell me anything. But looking back, the only thing I really knew was the sales jargon...
I’ve said it before, and I’ll say it again … you can absolutely lose your mind by trying to follow the news these days. That’s even more true if you’re trying to use the news as a resource to time...
Is a “big shift” at hand? That’s the question Wall Street is wrestling with here. And, naturally, the answer will have major implications for investors. Before I offer my answer to that...
It’s not a bold-sentence recommendation, and it’s based on an interview conducted by a journalist for a different media outlet. It’s Jon Markman, writing in the Aug. 10 issue of Pivotal Point: ...
The stock market is surging dramatically this morning, celebrating the U.S. election and an announcement by Pfizer that its COVID-19 vaccine is 90% effective. But I don’t envy Joe Biden. More...
We just endured an election “season” like no other. And true to brand for 2020, even long after the last ballots were cast, drama and uncertainty persist. The backdrop continues to be a...
The coronavirus crap is really getting old. And my highly unscientific polling of my friends shows a roughly equal split between those supporting lockdowns and those opposing lockdowns. ...
Any investor knows that the goal is to buy low and sell high. But, by the time a hot stock gets the media coverage, it’s too late. The fat cats on Wall Street have already collected their gains. ...
This is probably going to sound ridiculous, in a “Woodward’s garage freak” sort of way. But, here goes ... Someone on our staff — who’s in a position to see things like presidential campaigns’...